TABLE 4.
Indicators with statistically significant differences between three groups via univariate analysis during admission
| Variable | Mild group | Moderate group | Critical severe or severe group | F/H | p |
|---|---|---|---|---|---|
| LYM (×109) | 1.31 (1.15, 1.75) | 0.95 (0.74, 1.33) | 1.01 (0.56, 1.39) | 10.258 | 0.006 |
| NEU% (%) | 54.94 ± 14.65 | 69.913 ± 12.8816 | 66.03 ± 20.12 | 5.021 | 0.009 |
| LYM% (%) | 33.00 ± 14.35 | 20.37 ± 10.00 | 23.43 ± 15.57 | 5.354 | 0.007 |
| Albumin (g/L) | 41.76 ± 5.85 | 39.08 ± 3.16 | 36.58 ± 3.87 | 8.106 | 0.001 |
| ALT (U/L) | 26.00 (25.40, 29.89) | 17.35 (13.64, 31.22) | 39.10 (23.93, 72.65) | 11.718 | 0.003 |
| LDH (U/L) | 158.60 (131.00, 213.33) | 179.80 (156.00, 213.33) | 195.20 (178.00, 239.80) | 6.100 | 0.047 |
| Elevated NEU% | 1 (5.6) | 10 (32.2) | 13 (52.0) | 10.163 | 0.006 |
| Decreased LYM | 3 (16.7) | 16 (51.6) | 15 (60.0) | 8.486 | 0.014 |
| Decreased Albumin | 6 (33.3) | 20 (64.5) | 20 (80.0) | 9.683 | 0.008 |
| Elevated ALT | 3 (16.7) | 6 (19.4) | 12 (48.0) | 7.095 | 0.029 |
| Elevated T‐BIL | 0 (0.0) | 9 (29.0) | 2 (8.0) | 8.869 | 0.012 |
| Elevated Mb | 1 (5.6) | 8 (25.8) | 15 (60.0) | 15.019 | 0.001 |